Please assess the completion status of the following clinical trial:

Trial Title: Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 5.0

Eligibility Criteria:
Main Inclusion Criteria:~Experiencing moderate to severe pain after extraction of impacted third molars~Main Exclusion Criteria:~Any ongoing painful condition other than that associated with the current third molar surgery that could significantly interfere with the subject's suitability Any condition that would render the subject unsuitable to receive an NSAID, acetaminophen or codeine

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ibuprofen/acetaminophen (lower dose) (Type: EXPERIMENTAL): One tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet
- Ibuprofen/acetaminophen (higher dose) (Type: EXPERIMENTAL): Two tablets of ibuprofen 200 mg plus acetaminophen 500 mg
- Nurofen Plus® (Type: ACTIVE_COMPARATOR): Two tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®)
- Panadeine® Extra (Type: ACTIVE_COMPARATOR): Two tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra)
- Placebo (Type: PLACEBO_COMPARATOR): Two placebo tablets

Based on this trial design, predict the completion outcome and termination type (if applicable).